NEW YORK, NY, UNITED STATES, March 20, 2026 /EINPresswire.com/ -- K-pop virtual idol group, PLAVE, has announced the ...

As the Middle East war rages on, a key market gauge shows market participants are now bracing for a sharp rise in U.S. inflation over the next year. The market-implied U.S. inflation rate over the ...

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will present new ...

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custo ...

Chronos- PD shows that biological changes associated with Parkinson's disease (PD) can emerge up to 12 years before clinical diagnosisUncovered reproducible early molecular signals and distinct molecu ...

The central limit theorem started as a bar trick for 18th-century gamblers. Now scientists rely on it every day.

Anthropic’s Claude AI can now generate interactive charts and diagrams directly inside chat, bringing real-time visual explanations to conversations.

Take our Readiness Self-Assessment to evaluate your skills and start your journey to success! Take the first step toward mastering data science with our tailored self-assessment tool. This resource ...

Global Anime Market a vibrant cultural and entertainment powerhouse, continues to capture the imagination of audiences worldwide. From ...

Pregnancy weight and biochemical markers measured in blood from women with gestational diabetes mellitus (GDM) were related to increased risk of poor pregnancy outcomes, suggesting a new direction for ...

WALTHAM, Mass. and BOULDER, Colo., Feb. 28, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined ...

Bezuclastinib mean TSS reduction deepens to –32.0 points at 48 weeks of treatment with further improvement shown across all measured symptoms 99% of patients achieve >50% reduction in serum tryptase ...